SEE THE RISK
BEFORE THE LASER FIRES!

AI-Assisted Planning for Refractive Laser Eye Surgery

RLES AI reads your diagnostic printouts, screens dozens of risk parameters, applies your devices' own nomograms and delivers a signature-ready surgical plan — in minutes, over a simple WhatsApp message.

READS THE DATAPentacam, Sirius, MS-39 & more — from photos
SCREENS THE RISKDozens of parameters, hidden risks detected
APPLIES THE NOMOGRAMYour device, your settings
REPORTS THE PLANSignature-ready PDF report
ONE PLAN, WORTH A THOUSAND SURGERIES.
AI PRECISION. SURGEON DECISION. THE BEST OUTCOME.

How It Works

YOUR AI ASSISTANT
AT YOUR SIDE.

As easy as a WhatsApp message. No forms, no software, no learning curve — between consultations or on your way out of the OR, RLES AI is with you.

STEP 1
Photo of Reports

Send photos or PDFs of the patient's topography, pachymetry, autorefraction and exam notes.

STEP 2
AI Analysis

Every value is read with its source, assigned to the correct eye, and run through the full safety engine.

STEP 3
Plan in Minutes

A branded, signature-ready PDF planning report is produced and delivered on the same line.

NO FORMS.
No paperwork. Just send and go.
NO SOFTWARE.
No installations. No learning curve.
NO EXTRA TIME.
Expert-level analysis within minutes.
Complete Platform

EVERY FLAWLESS SURGERY BEGINS
WITH A FLAWLESS PLAN.

Fourteen integrated modules cover the full journey of the refractive patient — from first screening to lifelong follow-up. Every recommendation is explainable, literature-backed, and always leaves the final decision with the surgeon.

Laser Surgery Planning

The Core Module

Pre-operative planning for SMILE · LASIK · iLASIK · Q-LASIK · PRK · T-PRK. All six procedures are tested against their own procedure-specific safety floors, your devices' nomograms are applied, and a signature-ready planning report is produced.

  • Tissue budget: PTA, RSB and RCT with procedure-specific floors
  • Post-op keratometry prediction and the binding 36–49 D window
  • Optical-zone alternatives with their trade-offs
  • Missing data is never assumed normal — it is named

Keratoconus & Ectasia Screening

Early Detection

Advanced multi-index analysis — BAD-D, ART, Kmax, ISK, IVA, CBI/TBI, posterior elevation — with a decision matrix and correlation-aware counting that never treats derived indices as independent evidence.

  • Borderline eyes trigger a clinical verification set (retinoscopy, biomicroscopy)
  • Runs even when device software says “Normal”
  • Risk stratification you can defend

Contact-Lens Warpage Detection

Finds What Devices Miss

Finds deformed corneas that device software labels “Normal”. Nine indicators are screened together; oedema-inflated pachymetry — which silently flatters PTA, RSB and RCT all at once — is caught before it can mislead a plan.

  • Multi-indicator analysis with lens-history interrogation
  • 3D surface reconstruction in every warpage analysis
  • No ablation is planned on unstable maps

Precision WFG / TG Planning

Alpins Vectors · ORA · Vector Planning

Plans by the source of astigmatism, not just the manifest cylinder. Alpins double-angle analysis separates corneal and lenticular components; when the mismatch (ORA) is significant, a 60/40 vector-planning target protects the patient's long-term outcome.

  • Device–mode mapping: Contoura, ORK-CAM, TOSCA/WASCA and more
  • “Values to enter on the planning screen” — directly transferable
  • Double-angle vector diagrams for each eye

Complication Prevention & Analysis

Before and After the OR

A prevention engine that detects the preconditions of free flap, buttonhole and ectasia at the planning stage — plus a confidential in-clinic analysis module that investigates adverse events with mimic tables, severity grading and root-cause analysis.

  • PTA/RSB/RCT floors · hinge planning · warpage screen
  • Root cause includes device condition and calibration
  • Understanding and prevention — not blame

Enhancement Retreatment Planning

Different Problem. Different Planning.

Tissue has already been spent and the cornea carries a previous lamellar plane. RLES AI checks refractive stability, calculates the cumulative tissue budget and recommends the safest route for each eye.

  • Re-lift vs surface ablation vs CIRCLE — time and tissue based
  • Re-cutting an old flap plane is never proposed
  • ICL pathway opens when tissue says no

Phakic ICL Referral

EVO / EVO+ Candidacy

When an eye is not suitable for laser, RLES AI shows the next best option — automatically. Indication ranges, age, endothelium and the notorious ACD measurement trap are all verified.

  • ACD confirmed from the endothelium — epithelial readings corrected
  • Myopia −0.5 to −20.0 D · hyperopia (CE) +0.5 to +16.0 D
  • Clear, signature-ready referral reasoning

Keratoconus Treatment Planning

CXL · CAIRS · ICRS

After detection comes the pathway: progression is assessed by consensus criteria, the CXL protocol is chosen by corneal thickness, and ring options are planned with brand-specific nomograms and femtosecond tunnel capability checks.

  • CXL ladder: Dresden, accelerated, hypoosmolar, CACXL
  • CAIRS and ICRS with brand-specific tunnel geometry
  • DALK/PK referral when limits are passed

Dry Eye Syndrome Analysis

TFOS DEWS II Framework

Detect. Classify. Optimize. Full two-arm DEWS II diagnosis with subtype and severity — plus an automatic tear-film signature screen that runs silently on every single topography you send.

  • OSDI/DEQ-5 · TBUT/NIBUT · osmolarity · staining · meibography
  • False-KC patterns caused by tear film are unmasked
  • No plan is finalised on an unstable surface

Presbyopia Planning

PRESBYOND · PresbyMAX · Monovision

AI-assisted candidate screening, personalized targets and expectation management for every presbyopic strategy — each plan run through the same tissue safety engine.

  • Dominance and tolerance testing, CL-trial guidance
  • Age-based near targets; full monovision not advised
  • Method comparison with published tolerance data

Refractive Passport & IOL Support

The Data Today. The Right IOL Tomorrow.

A one-page, bilingual, signed document the patient keeps for life — and history-based IOL support at cataract age. Standard formulas are not used on post-refractive eyes; hyperopic surprise is prevented with the right inputs.

  • Formula priority: Barrett True-K → Haigis-L → Shammas-PL
  • Consistency check against today's measurements
  • Verified inputs and reasoning — not just a number

Outcome Registry & Personal Nomogram

Grow With Every Case

Post-op results are recorded with a short message; efficacy, safety and predictability indices accumulate into your personal nomogram — and an adjustment is proposed only when your own statistics can defend it.

  • Alpins TIA · SIA · DV · CI · IOS on every astigmatic case
  • Proposals gated by 95% confidence intervals
  • Rolling window catches device drift early

Patient Information Report

Plain Language. Real Trust.

Once your decision is final, RLES AI writes a plain-language summary for the patient: why the treatment was found suitable, what the day looks like, the rules to follow and the follow-up calendar — reviewed and handed over by you.

  • Procedure-specific wording (LASIK, PRK, SMILE, ICL)
  • Compliance rules that prevent complications
  • Never a recommendation to the patient — your decision, explained

XAI — Explainable AI

It Teaches the Why

RLES AI does not just answer; it explains the rule, the formula and the literature behind every recommendation. Which index is borderline and why. Why the hinge goes in that direction. Why the optical zone takes that value.

  • Up-to-date literature support for every decision
  • A teaching and consulting tool for residents and specialists
  • Your knowledge deepens with every case
Built-In Protection

SAFETY ENGINE

Every plan — no exceptions — passes through binding safety floors before it reaches your signature. Designed to catch the one case before it ever reaches the operating room.

PTA SAFETYPercent tissue altered with a Kmax-dependent ceiling — the steeper the cornea, the tighter the limit.
RSB SAFETYResidual stromal bed floors specific to each procedure — LASIK, lenticule and surface each have their own.
RCT SAFETYResidual corneal thickness controlled independently of the flap — only reducing ablation repairs it.
POST-OP K WINDOWPredicted keratometry must stay within 36–49 D — every cornea's correction ceiling is computed.
MAXIMUM TREATABLE CORRECTIONNomogram and device limits respected for every single plan.
AGE & STABILITY RULESAge bands, 12-month refractive stability and medication/chronic-disease screening on every case.

AUTOMATICALLY TESTED. SAFETY VERIFIED. CONFIDENCE DELIVERED.

Device Nomogram Integration

EVERY DEVICE. EVERY SETTING.
ONE INTELLIGENT NOMOGRAM.

Register your clinic's devices once. From then on, every analysis applies the published nomograms and specifications of your platform — values are never substituted from another device.

EXCIMER LASERS

  • Alcon WaveLight EX500 — full specification, Contoura / T-CAT mapping
  • SCHWIND AMARIS 1050RS / 750S / 500E — dose-dependent transition zones, ORK-CAM
  • Zeiss MEL 90 & MEL 80 — Triple-A / TSA-ASA, TOSCA & WASCA via CRS-Master
  • Bausch + Lomb Technolas TENEO 317
  • Excelsius MICRON M7 / M7-H / M7-G
  • and more…

MICROKERATOMES & FEMTO

  • Med-Logics ML7 — full ring / vacuum / CLB blade nomogram
  • Moria M2 & One Use-Plus SBK — manufacturer tables
  • Bausch + Lomb Hansatome & Zyoptix XP
  • Zeiss VisuMax 500 / 800 · Alcon FS200 · IntraLase · Ziemer LDV
  • Diagnostics: Pentacam · Sirius · MS-39 · Topolyzer VARIO · Peramis
  • and more…

THE RIGHT DEVICE. THE RIGHT SETTING. THE RIGHT OUTCOME.

TWO EXPERTS FOR YOUR PATIENTS' EYES:
THE SURGEON AND RLES AI.

RLES AI never rules that surgery “cannot be done”. It shows the floors, the reasons and the ways out — the decision always rests with the surgeon.

About

A DEVELOPMENT OF
MCD TECHNOLOGIES INVESTMENT INC.

RLES AI® is a development and investment of MCD Technologies Investment Inc. — built rule by rule with founding refractive surgeons, verified against published device nomograms and current literature, and delivered as clinical decision support: for professional use, with the final clinical decision always resting with the surgeon.

Full platform launch: November 2026 — this page is an introduction while we complete onboarding for early-access clinics.

Early Access

REQUEST INFORMATION

Tell us who you are and we will get back to you with details, demo access and early-adopter conditions.

Thank you — your request has been received. We will get back to you shortly.
Something went wrong. Please try again, or email us directly.